Thioredoxin-interacting protein (txnip) is a glucocorticoid-regulated primary response gene involved in mediating glucocorticoid-induced apoptosis (Oncogene (2006) 25, (1903-1913) DOI: 10.1038/sj.onc.1209218));Thioredoxin-interacting protein (txnip) is a glucocorticoid-regulated primary response gene involved in mediating glucocorticoid-induced apoptosis

Oncogene

Volumn 25, Issue 13, 2006, Pages 1903-1913

  Wang, Z ^a   Rong, Y P ^a   Malone, M H ^a   Davis, M C ^a   Zhong, F ^a   Distelhorst, C W ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Dexamethasone induced gene; Glucocorticoid; Lymphoma; Thioredoxin interacting protein; txnip

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GLUCOCORTICOID RECEPTOR ANTAGONIST; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; MESSENGER RNA; MIFEPRISTONE; PROTEIN; THIOREDOXIN INTERACTING PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; GENE DELETION; GENE EXPRESSION; GENE INDUCTION; GENE MUTATION; GENE REPRESSION; GENE TARGETING; GENETIC TRANSFECTION; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RNA INTERFERENCE; T CELL LYMPHOMA; THYMOCYTE; TRANSCRIPTION INITIATION;

ANIMALIA; MURINAE;

EID: 33645284675     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1211001     Document Type: Erratum

References (46)

1. Ashwell JD, Lu FW, Vacchio MS. (2000). Annu Rev Immunol 18: 309-345.
2. Baker A, Payne CM, Briehl MM, Powis G. (1997). Cancer Res 57: 5162-5167.
3. Butler LM, Zhou X, Xu WS, Scher HI, Rifkind RA, Marks PA et al. (2002). Proc Natl Acad Sci USA 99: 11700-11705.
4. Cairns C, Gustafsson JA, Carlstedt-Duke J. (1991). Mol Endocrinol 5: 598-604.
5. Chapman MS, Askew DJ, Kuscuoglu U, Miesfeld RL. (1996). Mol Endocrinol 10: 967-978.
6. Chauhan D, Auclair D, Robinson EK, Hideshima T, Li G, Podar K et al. (2002). Oncogene 21: 1346-1358.
7. Chen KS, DeLuca HF. (1994). Biochim Biophys Acta 1219: 26-32.
8. Cohen JJ, Duke RC. (1984). J Immunol 132: 38-42.
9. Dieken ES, Miesfeld RL. (1992). Mol Cell Biol 12: 589-597.
10. Han SH, Jeon JH, Ju HR, Jung U, Kim KY, Yoo HS et al. (2003). Oncogene 22: 4035-4046.
11. Harmon JM, Norman MR, Fowlkes BJ, Thompson EB. (1979). J Cell Physiol 98: 267-278.
12. Helmberg A, Auphan N, Caelles C, Karin M. (1995). EMBO J 14: 452-460.
13. Jondal M, Pazirandeh A, Okret S. (2004). Trends Immunol 25: 595-600.
14. Junn E, Han SH, Im JY, Yang Y, Cho EW, Um HD et al. (2000). J Immunol 164: 6287-6295.
15. Kim KY, Shin SM, Kim JK, Paik SG, Yang Y, Choi I. (2004). Biochem Biophys Res Commun 315: 369-375.
16. Malone MH, Wang Z, Distelhorst CW. (2004). J Biol Chem 279: 52850-52859.
17. Minn AH, Hafele C, Shalev A. (2005). Endocrinology 146: 2397-2405.
18. Mullick J, Anandatheerthavarada HK, Amuthan G, Bhagwat SV, Biswas G, Camasamudram V et al. (2001). J Biol Chem 276: 18007-18017.
19. Nishinaka Y, Masutani H, Nakamura H, Yodoi J. (2001). Redox Rep 6: 289-295.
20. Nishiyama A, Matsui M, Iwata S, Hirota K, Masutani H, Nakamura H et al. (1999). J Biol Chem 274: 21645-21650.
21. Nordeen SK, Suh BJ, Kuhnel B, Hutchison CD. (1990). Mol Endocrinol 4: 1866-1873.
22. Oberg HH, Sipos B, Kalthoff H, Janssen O, Kabelitz D. (2004). Cell Death Differ 11: 674-684.
23. Park CG, Lee SY, Kandala G, Choi Y. (1996). Immunity 4: 583-591.
24. Planey SL, Abrams MT, Robertson NM, Litwack G. (2003). Cancer Res 63: 172-178.
25. Powis G, Montfort WR. (2001). Annu Rev Biophys Biomol Struct 30: 421-455.
26. Prefontaine GG, Lemieux ME, Giffin W, Schild-Poulter C, Pope L, LaCasse E et al. (1998). Mol Cell Biol 18: 3416-3430.
27. Qian N, Frank D, O'Keefe D, Dao D, Zhao L, Yuan L et al. (1997). Hum Mol Genet 6: 2021-2029.
28. Ramdas J, Harmon JM. (1998). Endocrinology 139: 3813-3821.
29. Reichardt HM, Kaestner KH, Tuckermann J, Kretz O, Wessely O, Bock R et al. (1998). Cell 93: 531-541.
30. Rho J, Gong S, Kim N, Choi Y. (2001). Mol Cell Biol 21: 8365-8370.
31. Saitoh T, Tanaka S, Koike T. (2001). J Neurochem 78: 1267-1276.
32. Schmidt S, Rainer J, Ploner C, Presul E, Riml S, Kofler R. (2004). Cell Death Differ 11(Suppl 1): S45-55.
33. Schoneveld OJ, Gaemers IC, Lamers WH. (2004). Biochim Biophys Acta 1680: 114-128.
34. Thompson EB. (1998). Steroids 63: 368-374.
35. Tome ME, Baker AF, Powis G, Payne CM, Briehl MM. (2001). Cancer Res 61: 2766-2773.
36. Tonomura N, McLaughlin K, Grimm L, Goldsby RA, Osborne BA. (2003). J Immunol 170: 2469-2478.
37. Torres-Roca JF, Tung JW, Greenwald DR, Brown JM, Herzenberg LA, Katsikis PD. (2000). J Immunol 165: 4822-4830.
38. Truss M, Chalepakis G, Beato M. (1990). Proc Natl Acad Sci USA 87: 7180-7184.
39. Wang R, Zhang L, Yin D, Mufson RA, Shi Y. (1998). J Immunol 161: 2201-2207.
40. Wang Y, De Keulenaer GW, Lee RT. (2002). J Biol Chem 277: 26496-26500.
41. Wang Z, Malone MH, He H, McColl KS, Distelhorst CW. (2003a). J Biol Chem 278: 23861-23867.
42. Wang Z, Malone MH, Thomenius MJ, Zhong F, Xu F, Distelhorst CW. (2003b). J Biol Chem 278: 27053-27058.
43. Webb MS, Miller AL, Johnson BH, Fofanov Y, Li T, Wood TG et al. (2003). J Steroid Biochem Mol Biol 85: 183-193.
44. Wyllie AH. (1980). Nature 284: 555-556.
45. Wyllie AH, Morris RG, Smith AL, Dunlop D. (1984). J Pathol 142: 67-77.
46. Yamawaki H, Pan S, Lee RT, Berk BC. (2005). J Clin Invest 115: 733-738.